Reports - Precision Medicine Market
HealthcarePrecision Medicine Market
Precision Medicine Market Valuation and Growth Forecast 2025-2035 by Type (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs, Other Therapeutic Products) by Indication (Oncology, Rare Diseases, Infectious diseases, Hematological disorders, Other indications) by End User (Hospitals and Clinics, Home care settings) by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Precision Medicine Market - Segment Analysis
1. Overview
2. Global Precision Medicine Market, 2021 - 2035 (USD Million)
3. Global Precision Medicine Market - by Type
3.1. By Inhibitor Drugs
3.2. By Monoclonal Antibodies
3.3. By Cell & Gene Therapy
3.4. By Antiviral & Anti-retroviral drugs
3.5. By Other Therapeutic Products
4. Global Precision Medicine Market - by Indication
4.1. By Oncology
4.2. By Rare Diseases
4.3. By Infectious diseases
4.4. By Hematological disorders
4.5. By Other indications
5. Global Precision Medicine Market - by End User
5.1. By Hospitals and Clinics
5.2. By Home care settings
6. Global Precision Medicine Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Precision Medicine Market - Segment Analysis
1. Overview
2. North America Precision Medicine Market, 2021 - 2035 (USD Million)
3. North America Precision Medicine Market - by Type
3.1. By Inhibitor Drugs
3.2. By Monoclonal Antibodies
3.3. By Cell & Gene Therapy
3.4. By Antiviral & Anti-retroviral drugs
3.5. By Other Therapeutic Products
4. North America Precision Medicine Market - by Indication
4.1. By Oncology
4.2. By Rare Diseases
4.3. By Infectious diseases
4.4. By Hematological disorders
4.5. By Other indications
5. North America Precision Medicine Market - by End User
5.1. By Hospitals and Clinics
5.2. By Home care settings
Chapter 5 Europe Precision Medicine Market - Segment Analysis
1. Overview
2. Europe Precision Medicine Market, 2021 - 2035 (USD Million)
3. Europe Precision Medicine Market - by Type
3.1. By Inhibitor Drugs
3.2. By Monoclonal Antibodies
3.3. By Cell & Gene Therapy
3.4. By Antiviral & Anti-retroviral drugs
3.5. By Other Therapeutic Products
4. Europe Precision Medicine Market - by Indication
4.1. By Oncology
4.2. By Rare Diseases
4.3. By Infectious diseases
4.4. By Hematological disorders
4.5. By Other indications
5. Europe Precision Medicine Market - by End User
5.1. By Hospitals and Clinics
5.2. By Home care settings
Chapter 6 Asia Pacific Precision Medicine Market - Segment Analysis
1. Overview
2. Asia Pacific Precision Medicine Market, 2021 - 2035 (USD Million)
3. Asia Pacific Precision Medicine Market - by Type
3.1. By Inhibitor Drugs
3.2. By Monoclonal Antibodies
3.3. By Cell & Gene Therapy
3.4. By Antiviral & Anti-retroviral drugs
3.5. By Other Therapeutic Products
4. Asia Pacific Precision Medicine Market - by Indication
4.1. By Oncology
4.2. By Rare Diseases
4.3. By Infectious diseases
4.4. By Hematological disorders
4.5. By Other indications
5. Asia Pacific Precision Medicine Market - by End User
5.1. By Hospitals and Clinics
5.2. By Home care settings
Chapter 7 Latin America Precision Medicine Market - Segment Analysis
1. Overview
2. Latin America Precision Medicine Market, 2021 - 2035 (USD Million)
3. Latin America Precision Medicine Market - by Type
3.1. By Inhibitor Drugs
3.2. By Monoclonal Antibodies
3.3. By Cell & Gene Therapy
3.4. By Antiviral & Anti-retroviral drugs
3.5. By Other Therapeutic Products
4. Latin America Precision Medicine Market - by Indication
4.1. By Oncology
4.2. By Rare Diseases
4.3. By Infectious diseases
4.4. By Hematological disorders
4.5. By Other indications
5. Latin America Precision Medicine Market - by End User
5.1. By Hospitals and Clinics
5.2. By Home care settings
Chapter 8 Middle East & Africa Precision Medicine Market - Segment Analysis
1. Overview
2. Middle East & Africa Precision Medicine Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Precision Medicine Market - by Type
3.1. By Inhibitor Drugs
3.2. By Monoclonal Antibodies
3.3. By Cell & Gene Therapy
3.4. By Antiviral & Anti-retroviral drugs
3.5. By Other Therapeutic Products
4. Middle East & Africa Precision Medicine Market - by Indication
4.1. By Oncology
4.2. By Rare Diseases
4.3. By Infectious diseases
4.4. By Hematological disorders
4.5. By Other indications
5. Middle East & Africa Precision Medicine Market - by End User
5.1. By Hospitals and Clinics
5.2. By Home care settings
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Pfizer Inc.
2. Hoffmann-La Roche Ltd.
3. Novartis AG
4. Bristol Myers Squibb
5. AstraZeneca
6. Gilead Sciences Inc.
7. Eli Lilly and Company
8. GlaxoSmithKline plc
9. Sanofi
10. Johnson & Johnson
11. Merck KGaA
12. Amgen Inc.
13. AbbVie Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By